CLIMATE
VEGF Receptor Antibody, KDR1.3
About
Clone KDR 1.3 is a locally developed monoclonal antibody that determines the total protein level of VEGFR-2 and allows for quantitative analysis.
- High specificity in Western Blot and ELISA applications,
- Monitoring receptor expression changes related to treatment response,
- Target validation in cancer cell models
is suitable for their work.
This product reveals differences in the biological regulation of VEGFR-2 through comprehensive molecular evaluation.
Product Overview
Recombinant antibody (ScFv) with potential for use in the treatment of Cancer Patients.
Product Name
VEGF Receptor Antibody, KDR 1.3
Product Short/Code Name
KDR 1.3
Product Type
Prototype Product
Area of Use
In cancer patients
Developer Research Groups
Biotechnology Research Group
Production and Technology Status
Technology Readiness Level (THS)
THS 4
Technical Specifications
Biotechnological Drug Candidate
Recombinant Antibody
